Quick Takeaways
- RTW INVESTMENTS, LP filed SCHEDULE 13G/A for APOGEE THERAPEUTICS, INC. Common Stock, $0.00001 par value (APGE).
- Disclosed ownership: 4.9%.
- Date of event: 31 Dec 2025.
RTW INVESTMENTS, LP - 31 Dec 2025 SCHEDULE 13G/A Report for APOGEE THERAPEUTICS, INC. Common Stock, $0.00001 par value (APGE)
- Filing Manager
- RTW INVESTMENTS, LP
- Reporting Manager
- RTW Investments, LP
- Symbol
- APGE
- Shares outstanding
- 55,348,918 shares
- Disclosed Ownership
- 2,712,097 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 08:27:08 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"RTW INVESTMENTS, LP disclosed 4.9% ownership in APOGEE THERAPEUTICS, INC. Common Stock, $0.00001 par value (APGE) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 17 Feb 2026, 08:27.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RTW Investments, LP | 4.9% | 2,712,097 | 0 | 2,712,097 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D., Managing Partner | |
| Roderick Wong | 4.9% | 2,712,097 | 0 | 2,712,097 | s/ Roderick Wong, M.D. | Roderick Wong, M.D. |